These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 3252981)

  • 1. Sero-conversion of infants to three doses of oral poliomyelitis vaccine.
    Tswana SA; Berejena C
    Cent Afr J Med; 1988 Dec; 34(12):290-4. PubMed ID: 3252981
    [No Abstract]   [Full Text] [Related]  

  • 2. [Humoral antibodies, coproantibodies and viral excretion in newborn infants immunized with poliomyelitis vaccine].
    Ruíz-Gómez J; Caloca García MA; Longega Escobio P
    Salud Publica Mex; 1979; 21(2):127-34. PubMed ID: 231330
    [No Abstract]   [Full Text] [Related]  

  • 3. [Preventive poliomyelitis immunization].
    Böthig B
    Z Arztl Fortbild (Jena); 1990; 84(8):365-7. PubMed ID: 2165712
    [No Abstract]   [Full Text] [Related]  

  • 4. A survey to determine the immunity status and antibody creating effect of oral polio vaccine.
    Forbes CA; Fernando NI; de la Motte PU; Mendis NM
    J Trop Med Hyg; 1980 Jun; 83(3):109-13. PubMed ID: 7401217
    [No Abstract]   [Full Text] [Related]  

  • 5. Randomized trial of inactivated and live polio vaccine schedules in Guatemalan infants.
    Asturias EJ; Dueger EL; Omer SB; Melville A; Nates SV; Laassri M; Chumakov K; Halsey NA
    J Infect Dis; 2007 Sep; 196(5):692-8. PubMed ID: 17674310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cross-sectional sero epidemiological prevalence of polio virus antibodies post-immunization with three doses of TOPV.
    Tswana SA; Berejena C; Moyo SR; Mudyarabikwa O
    Cent Afr J Med; 1994 Nov; 40(11):303-5. PubMed ID: 7859270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sero-conversion after oral polio vaccine.
    Hardas UD; Pathak AA; Jahagirdar VL
    Indian J Pediatr; 1978 Oct; 45(369):310-3. PubMed ID: 220192
    [No Abstract]   [Full Text] [Related]  

  • 8. Herd immunity to poliovirus in Dundee.
    Smith WC; Small RG; Dunkerley RA; Green DM
    Health Bull (Edinb); 1982 Nov; 40(6):296-305. PubMed ID: 6298147
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comment on the contribution by Pietsch, R., H. Riegel: Implementation of poliomyelitis revaccination].
    Dittmann S; Koch MA; Diedrich S; Maass G; Böthig B
    Gesundheitswesen; 1993 Jul; 55(7):381-3. PubMed ID: 8396469
    [No Abstract]   [Full Text] [Related]  

  • 10. The status of poliomyelitis in Venezuela.
    Echezuría E
    Bull Pan Am Health Organ; 1974; 8(1):66-71. PubMed ID: 4371606
    [No Abstract]   [Full Text] [Related]  

  • 11. [Poliomyelitis associated with a vaccine: 2 clinical cases].
    González E; Cordero J
    Rev Med Chil; 1988 May; 116(5):461-4. PubMed ID: 2854294
    [No Abstract]   [Full Text] [Related]  

  • 12. [Observation on immunizing effect of live trivalent oral poliomyelitis vaccine].
    Hu XM
    Zhonghua Yu Fang Yi Xue Za Zhi; 1982 Sep; 16(5):285-9. PubMed ID: 7151589
    [No Abstract]   [Full Text] [Related]  

  • 13. Monovalent oral poliovirus vaccines--a good tool but not a total solution.
    Ehrenfeld E; Chumakov K
    N Engl J Med; 2008 Oct; 359(16):1726-7. PubMed ID: 18923176
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comment on the contribution by R. Pietsch and H. Riegel: "Implementation of poliomyelitis revaccination"].
    Volkmer KJ; Kröger E
    Gesundheitswesen; 1993 Jul; 55(7):380. PubMed ID: 8396468
    [No Abstract]   [Full Text] [Related]  

  • 15. Eradication of poliomyelitis in Cuba: a historical perspective.
    Más Lago P
    Bull World Health Organ; 1999; 77(8):681-7. PubMed ID: 10516790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serum conversion rate following oral poliomyelitis immunization in Mali, Africa 1982].
    Ehrengut W; AgRhaly A; Koch I; Koumaré B; Simaga SY; Diallo D
    Monatsschr Kinderheilkd; 1984 Jan; 132(1):29-31. PubMed ID: 6321963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody response to three doses of conventional and double-dose OPV and to six doses of conventional OPV.
    Jhala CI; Goel RK
    Indian Pediatr; 1981 Jun; 18(6):379-83. PubMed ID: 6269996
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunogenicity of oral poliovirus vaccine administered in mass campaigns versus routine immunization programmes.
    Richardson G; Linkins RW; Eames MA; Wood DJ; Campbell PJ; Ankers E; Deniel M; Kabbaj A; Magrath DI; Minor PD
    Bull World Health Organ; 1995; 73(6):769-77. PubMed ID: 8907770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A seroprevalence study of poliovirus antibody in the population of northern Greece.
    Frantzidou F; Diza E; Halkia D; Antoniadis A
    Clin Microbiol Infect; 2005 Jan; 11(1):68-71. PubMed ID: 15649308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2001 serological survey in the Czech Republic--poliomyelitis.
    Matyásová I; Rainetová P; Cástková J
    Cent Eur J Public Health; 2003 Dec; 11 Suppl():S31-5. PubMed ID: 15080257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.